Nonviral gene delivery of erythropoietin by mesenchymal stromal cells

Gene Therapy

Volumn 19, Issue 5, 2012, Pages 550-560

  Scheibe, F ^a,b   Gladow, N ^a   Mergenthaler, P ^a   Tucker, A H ^c   Meisel, A ^a   Prockop, D J ^c   Priller, J ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Berlin Brandenburg Center for Regenerative Therapies   (Germany)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

erythropoietin; lipofection; magnetofection; mesenchymal stem cells; nucleofection

Indexed keywords

CD11B ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CD86 ANTIGEN; ENHANCED GREEN FLUORESCENT PROTEIN; ERYTHROPOIETIN; HEMOGLOBIN; STEM CELL FACTOR RECEPTOR;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CARTILAGE CELL; CELL ISOLATION; CELL POPULATION; CELL PROLIFERATION; COLONY FORMING UNIT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; GENE TRANSFER; GENETIC TRANSFECTION; HEMATOCRIT; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OSTEOBLAST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; ERYTHROPOIETIN; GENE THERAPY; GENETIC VECTORS; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; PLASMIDS; TRANSFECTION;

MURINAE; MUS;

EID: 84862145788     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2011.139     Document Type: Article

References (44)

1. Lin FK, Suggs S, Lin CH, Browne JK, Smalling R, Egrie JC et al. Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci USA 1985; 82: 7580-7584. (Pubitemid 16204391)
2. Ruscher K, Freyer D, Karsch M, Isaev N, Megow D, Sawitzki B et al. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J Neurosci 2002; 22: 10291-10301. (Pubitemid 35416867)
3. Arcasoy MO. The non-haematopoietic biological effects of erythropoietin. Br J Haematol 2008; 141: 14-31. (Pubitemid 351347536)
4. Osada S, Ebihara I, Setoguchi Y, Takahashi H, Tomino Y, Koide H. Gene therapy for renal anemia in mice with polycystic kidney using an adenovirus vector encoding the human erythropoietin gene. Kidney Int 1999; 55: 1234-1240. (Pubitemid 29157119)
5. Oh TK, Quan GH, Kim HY, Park F, Kim ST. Correction of anemia in uremic rats by intramuscular injection of lentivirus carrying an erythropoietin gene. Am J Nephrol 2006; 26: 326-334. (Pubitemid 44394150)
6. Daga A, Muraglia A, Quarto R, Cancedda R, Corte G. Enhanced engraftment of EPOtransduced human bone marrow stromal cells transplanted in a 3D matrix in nonconditioned NOD/SCID mice. Gene Therapy 2002; 9: 915-921. (Pubitemid 34812281)
7. Voutetakis A, Zheng C, Cotrim AP, Mineshiba F, Afione S, Roescher N et al. AAV5-mediated gene transfer to the parotid glands of non-human primates. Gene Therapy 2010; 17: 50-60.
8. Svensson EC, Black HB, Dugger DL, Tripathy SK, Goldwasser E, Hao Z et al. Long-term erythropoietin expression in rodents and non-human primates following intramuscular injection of a replication-defective adenoviral vector. Hum Gene Ther 1997; 8: 1797-1806. (Pubitemid 27488929)
9. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147. (Pubitemid 29282067)
10. Pereira RF, Halford KW, O'Hara MD, Leeper DB, Sokolov BP, Pollard MD et al. Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci USA 1995; 92: 4857-4861.
11. Sanz L, Compte M, Guijarro-Muñ oz I, Á lvarez-Vallina L. Non-hematopoietic stem cells as factories for in vivo therapeutic protein production. Gene Therapy 2011; e-pub ahead of print 12 May 2011; doi:10.1038/gt.2011.68.
12. Caplan AI. Why are MSCs therapeutic? New data: new insight. J Pathol 2009; 217: 318-324.
13. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838-3843. (Pubitemid 34534559)
14. Bartholomew A, Patil S, Mackay A, Nelson M, Buyaner D, Hardy W et al. Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo. Hum Gene Ther 2001; 12: 1527-1541. (Pubitemid 34248288)
15. Yokoo T, Fukui A, Matsumoto K, Ohashi T, Sado Y, Suzuki H et al. Generation of a transplantable erythropoietin-producer derived from human mesenchymal stem cells. Transplantation 2008; 85: 1654-1658.
16. Eliopoulos N, Al Khaldi A, Crosato M, Lachapelle K, Galipeau J. A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice. Gene Therapy 2003; 10: 478-489. (Pubitemid 36395265)
17. Copland IB, Jolicoeur EM, Gillis MA, Cuerquis J, Eliopoulos N, Annabi B et al. Coupling erythropoietin secretion to mesenchymal stromal cells enhances their regenerative properties. Cardiovasc Res 2008; 79: 405-415.
18. Eliopoulos N, Gagnon RF, Francois M, Galipeau J. Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failure. J Am Soc Nephrol 2006; 17: 1576-1584. (Pubitemid 43794660)
19. Kurozumi K, Nakamura K, Tamiya T, Kawano Y, Ishii K, Kobune M et al. Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol Ther 2005; 11: 96-104. (Pubitemid 40012003)
20. Eliopoulos N, Lejeune L, Martineau D, Galipeau J. Human-compatible collagen matrix for prolonged and reversible systemic delivery of erythropoietin in mice from genemodified marrow stromal cells. Mol Ther 2004; 10: 741-748. (Pubitemid 39272863)
21. Campeau PM, Rafei M, Francois M, Birman E, Forner KA, Galipeau J. Mesenchymal stromal cells engineered to express erythropoietin induce anti-erythropoietin antibodies and anemia in allorecipients. Mol Ther 2009; 17: 369-372.
22. Phillips JE, Gersbach CA, Garcia AJ. Virus-based gene therapy strategies for bone regeneration. Biomaterials 2007; 28: 211-229. (Pubitemid 44537380)
23. Gothelf A, Hojman P, Gehl J. Therapeutic levels of erythropoietin (EPO) achieved after gene electrotransfer to skin in mice. Gene Therapy 2010; 17: 1077-1084.
24. Gothelf A, Eriksen J, Hojman P, Gehl J. Duration and level of transgene expression after gene electrotransfer to skin in mice. Gene Therapy 2010; 17: 839-845.
25. Eguchi H, Kuroiwa Y, Matsui A, Sada M, Nagaya N, Kawano S. Intra-bone marrow cotransplantation of donor mesenchymal stem cells in pig-to-NOD/SCID mouse bone marrow transplantation facilitates short-term xenogeneic hematopoietic engraftment. Transplant Proc 2008; 40: 574-577. (Pubitemid 351406459)
26. Coyne TM, Marcus AJ, Reynolds K, Black IB, Woodbury D. Disparate host response and donor survival after the transplantation of mesenchymal or neuroectodermal cells to the intact rodent brain. Transplantation 2007; 84: 1507-1516. (Pubitemid 350294727)
27. Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009; 5: 54-63.
28. Ozawa T, Toba K, Suzuki H, Kato K, Iso Y, Akutsu Y et al. Single-dose intravenous administration of recombinant human erythropoietin is a promising treatment for patients with acute myocardial infarction. Circ J 2010; 74: 1415-1423.
29. Price MJ, Chou CC, Frantzen M, Miyamoto T, Kar S, Lee S et al. Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties. Int J Cardiol 2006; 111: 231-239. (Pubitemid 44107562)
30. Breitbach M, Bostani T, Roell W, Xia Y, Dewald O, Nygren JM et al. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 2007; 110: 1362-1369. (Pubitemid 47281438)
31. Eliopoulos N, Stagg J, Lejeune L, Pommey S, Galipeau J. Allogeneic marrow stromal cells are immune rejected by MHC class I-and class II-mismatched recipient mice. Blood 2005; 106: 4057-4065. (Pubitemid 41775910)
32. Sauerborn M, Brinks V, Jiskoot W, Schellekens H. Immunological mechanism underlying the immune response to recombinant human protein therapeutics. Trends Pharmacol Sci 2010; 31: 53-59.
33. Schellekens H. Factors influencing the immunogenicity of therapeutic proteins. Nephrol Dial Transplant 2005; 20 (Suppl 6): vi3-vi9.
34. McMahon JM, Conroy S, Lyons M, Greiser U, O'shea C, Strappe P et al. Gene transfer into rat mesenchymal stem cells: a comparative study of viral and nonviral vectors. Stem Cells Dev 2006; 15: 87-96.
35. Colleoni S, Donofrio G, Lagutina I, Duchi R, Galli C, Lazzari G. Establishment, differentiation, electroporation, viral transduction, and nuclear transfer of bovine and porcine mesenchymal stem cells. Cloning Stem Cells 2005; 7: 154-166. (Pubitemid 43150271)
36. Aslan H, Zilberman Y, Arbeli V, Sheyn D, Matan Y, Liebergall M et al. Nucleofectionbased ex vivo nonviral gene delivery to human stem cells as a platform for tissue regeneration. Tissue Eng 2006; 12: 877-889. (Pubitemid 43726529)
37. Ferreira E, Potier E, Logeart-Avramoglou D, Salomskaite-Davalgiene S, Mir LM, Petite H. Optimization of a gene electrotransfer method for mesenchymal stem cell transfection. Gene Therapy 2008; 15: 537-544. (Pubitemid 351405094)
38. Aluigi M, Fogli M, Curti A, Isidori A, Gruppioni E, Chiodoni C et al. Nucleofection is an efficient nonviral transfection technique for human bone marrow-derived mesenchymal stem cells. Stem Cells 2006; 24: 454-461. (Pubitemid 44464815)
39. Nakashima S, Matsuyama Y, Nitta A, Sakai Y, Ishiguro N. Highly efficient transfection of human marrow stromal cells by nucleofection. Transplant Proc 2005; 37: 2290-2292. (Pubitemid 40956434)
40. Zaragosi LE, Billon N, Ailhaud G, Dani C. Nucleofection is a valuable transfection method for transient and stable transgene expression in adipose tissue-derived stem cells. Stem Cells 2007; 25: 790-797. (Pubitemid 46354239)
41. Gheisari Y, Soleimani M, Azadmanesh K, Zeinali S. Multipotent mesenchymal stromal cells: optimization and comparison of five cationic polymer-based gene delivery methods. Cytotherapy 2008; 10: 815-823.
42. Laker C, Meyer J, Schopen A, Friel J, Heberlein C, Ostertag W et al. Host cis-mediated extinction of a retrovirus permissive for expression in embryonal stem cells during differentiation. J Virol 1998; 72: 339-348. (Pubitemid 28048845)
43. Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF, Prockop DJ. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 2004; 103: 1662-1668. (Pubitemid 38268957)
44. Sekiya I, Larson BL, Vuoristo JT, Reger RL, Prockop DJ. Comparison of effect of BMP-2,-4, and-6 on in vitro cartilage formation of human adult stem cells from bone marrow stroma. Cell Tissue Res 2005; 320: 269-276. (Pubitemid 40684753)